SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 59 filers reported holding SIO GENE THERAPIES INC in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $30,852 | +54.3% | 70,925 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | -23.1% | 70,925 | -0.1% | 0.00% | – |
| Q2 2022 | $26,000 | -59.4% | 71,025 | -25.6% | 0.00% | – |
| Q1 2022 | $64,000 | +64.1% | 95,446 | +211.8% | 0.00% | – |
| Q4 2021 | $39,000 | -89.6% | 30,607 | -82.3% | 0.00% | -100.0% |
| Q3 2021 | $376,000 | -62.3% | 173,137 | -52.6% | 0.00% | -50.0% |
| Q2 2021 | $998,000 | -30.3% | 365,392 | -33.3% | 0.00% | -50.0% |
| Q1 2021 | $1,431,000 | – | 548,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cladis Investment Advisory, LLC | 1,126,000 | $754,000 | 0.72% |
| Prosight Management, LP | 670,300 | $449,000 | 0.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $3,962,000 | 0.12% |
| ACT CAPITAL MANAGEMENT, LLC | 146,500 | $98,000 | 0.10% |
| Rubric Capital Management LP | 3,000,000 | $2,010,000 | 0.07% |
| Clearline Capital LP | 392,691 | $263,000 | 0.03% |
| APOGEM CAPITAL LLC | 49,528 | $33,000 | 0.02% |
| Hudson Bay Capital Management LP | 1,682,000 | $1,127,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,900 | $164,000 | 0.00% |
| NORTHERN TRUST CORP | 87,153 | $58,000 | 0.00% |